Inotuzumab ozogamicin for treating pediatric R/R ALL

Inotuzumab ozogamicin for treating pediatric R/R ALL

Blinatumomab and inotuzumab in children with R/R B-ALLПодробнее

Blinatumomab and inotuzumab in children with R/R B-ALL

Improving adult ALL treatment: pediatric regimens & adding inotuzumabПодробнее

Improving adult ALL treatment: pediatric regimens & adding inotuzumab

Inotuzumab ozogamicin in paediatric CD22-positive r/r acute lymphoblastic leukaemia: results of ...Подробнее

Inotuzumab ozogamicin in paediatric CD22-positive r/r acute lymphoblastic leukaemia: results of ...

Alliance A041501: the addition of inotuzumab to a pediatric-inspired chemo regimen for B-ALLПодробнее

Alliance A041501: the addition of inotuzumab to a pediatric-inspired chemo regimen for B-ALL

Inotuzumab ozogamicin in the treatment of patients with R/R ALL and extramedullary diseaseПодробнее

Inotuzumab ozogamicin in the treatment of patients with R/R ALL and extramedullary disease

Azacitidine and venetoclax +/- gemtuzumab ozogamicin in pediatric patients with R/R acute leukemiasПодробнее

Azacitidine and venetoclax +/- gemtuzumab ozogamicin in pediatric patients with R/R acute leukemias

Choosing between inotuzumab ozogamicin and blinatumomab in patients with R/R ALLПодробнее

Choosing between inotuzumab ozogamicin and blinatumomab in patients with R/R ALL

The evolving role of inotuzumab ozogamicin in the treatment of pediatric & older patients with ALLПодробнее

The evolving role of inotuzumab ozogamicin in the treatment of pediatric & older patients with ALL

Phase II trial of inotuzumab ozogamicin to treat MRD+ B-ALLПодробнее

Phase II trial of inotuzumab ozogamicin to treat MRD+ B-ALL

Treatment Advances for Acute Lymphoblastic Leukemia (ALL) In Children and AdultsПодробнее

Treatment Advances for Acute Lymphoblastic Leukemia (ALL) In Children and Adults

Addition of blinatumomab to mini-hyper-CVD and inotuzumab improves outcomes in R/R ALLПодробнее

Addition of blinatumomab to mini-hyper-CVD and inotuzumab improves outcomes in R/R ALL

Phase II study of inotuzumab ozogamicin in MRD+ B-ALLПодробнее

Phase II study of inotuzumab ozogamicin in MRD+ B-ALL

A Phase II study of ruxolitinib with chemotherapy in pediatric patients with Ph-like ALLПодробнее

A Phase II study of ruxolitinib with chemotherapy in pediatric patients with Ph-like ALL

Inotuzumab ozogamicin for MRD-positive B-ALLПодробнее

Inotuzumab ozogamicin for MRD-positive B-ALL

Pediatric Rheumatology at Children's of AlabamaПодробнее

Pediatric Rheumatology at Children's of Alabama

Dr. Brammer on Data With Inotuzumab Ozogamicin in ALLПодробнее

Dr. Brammer on Data With Inotuzumab Ozogamicin in ALL

What is the role of inotuzumab ozogamicin in ALLПодробнее

What is the role of inotuzumab ozogamicin in ALL

Management Perspective of Pediatric ALL and AML_Dr Amita MahajanПодробнее

Management Perspective of Pediatric ALL and AML_Dr Amita Mahajan

Treating pediatric patients with hematological malignanciesПодробнее

Treating pediatric patients with hematological malignancies